Photo by charlesdeluvio from unsplash
Oral sotalol initiation requires a multiple‐day, inpatient admission to monitor for QT prolongation during loading. A 1‐day intravenous (IV) sotalol loading protocol was approved by the United States Food and… Click to show full abstract
Oral sotalol initiation requires a multiple‐day, inpatient admission to monitor for QT prolongation during loading. A 1‐day intravenous (IV) sotalol loading protocol was approved by the United States Food and Drug Administration in March 2020, but limited data on clinical use and administration currently exists. This study describes implementation of an IV sotalol protocol within an integrated health system, provides initial efficacy and safety outcomes, and examines length of stay (LOS) compared with oral sotalol initiation.
Journal Title: Journal of Cardiovascular Electrophysiology
Year Published: 2023
Link to full text (if available)
Share on Social Media: Sign Up to like & get
recommendations!